Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by HuntNGatheron Mar 18, 2013 12:06am
327 Views
Post# 21143782

Canadian Insider showing insider participation

Canadian Insider showing insider participation

Some days I think that I don't know too much about investing.

What I do know is that when insiders who are heavily invested put more money down at a price... I am happy to put my money down under the same terms.

Dean Peterson is in for another $100K as part of the financing, in addition to all his other holdings from the past few years.

I can't see the full extent of insider participation on Canadian Insider but suspect that it is going to be more extensive than that.

HnG

Bullboard Posts